Nectar Lifesciences Limited (LUX: NECLF)

Market Cap	101.72M
Revenue (ttm)	179.70M
Net Income (ttm)	1.15M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	88.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.388
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 11, 2025

About Nectar Lifesciences

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company’s active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablet...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1995
• Employees: 1,686
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: NECLF

Financial Performance

Financial numbers in INR